LakeShore Biopharma logo

LakeShore BiopharmaNASDAQ: LSB

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

China

IPO:

05 August 2021

Next earnings report:

25 September 2024

Last dividends:

N/A

Next dividends:

N/A
$118.28 M
-87%vs. 3y high
46%vs. sector
-vs. 3y high
-vs. sector
-39%vs. 3y high
49%vs. sector
-80%vs. 3y high
47%vs. sector

Price

after hours | Fri, 13 Sep 2024 23:43:57 GMT
$0.62+$0.07(+12.93%)

Dividend

No data over the past 3 years
$13.38 M$22.14 M
$13.38 M-$14.51 M

Analysts recommendations

Institutional Ownership

LSB Latest News

LakeShore Biopharma Announces Leadership Transitions
prnewswire.com04 September 2024 Sentiment: NEUTRAL

GAITHERSBURG, Md. , Sept. 4, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd.

LakeShore Biopharma Announces Financial Results for Fiscal Year 2024
prnewswire.com15 August 2024 Sentiment: POSITIVE

Gross margin increased to 79.5%; product pipeline continues to advance Company anticipates double-digit year-over-year revenue growth and bottom line breakeven for Fiscal Year 2025 GAITHERSBURG, Md. , Aug. 15, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd.

What type of business is LakeShore Biopharma?

LakeShore Biopharma Co., Ltd, a biopharmaceutical company, engages in the discovering, developing, manufacturing, commercializing, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. The company's product pipeline includes YSJA, a conventional rabies vaccine which is in marketed stage; PIKA, a rabies vaccine which are in phase I/III and preclinical trials for the treatment of rabies virus; PIKA YS-ON-001, an immuno-oncology therapeutic that is in phase I trials for the treatment of pancreatic and hepatocellular cancer; PIKA YS-HBV-001, a hepatitis B vaccine that is in phase I trials; PIKA YS-HBV-002, an immune-therapy vaccine which is in IND preclinical trials for the treatment of chronic HBV infection; and PIKA YS-ON-001 and PIKA Influenza Vaccine which are in preclinical trials. It operates in China, Singapore, the United States, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. The company was founded in 2002 and is based in Beijing, China.

What sector is LakeShore Biopharma in?

LakeShore Biopharma is in the Healthcare sector

What industry is LakeShore Biopharma in?

LakeShore Biopharma is in the Biotechnology industry

What country is LakeShore Biopharma from?

LakeShore Biopharma is headquartered in China

When did LakeShore Biopharma go public?

LakeShore Biopharma initial public offering (IPO) was on 05 August 2021

What is LakeShore Biopharma website?

https://www.ysbiopharm.com

Is LakeShore Biopharma in the S&P 500?

No, LakeShore Biopharma is not included in the S&P 500 index

Is LakeShore Biopharma in the NASDAQ 100?

No, LakeShore Biopharma is not included in the NASDAQ 100 index

Is LakeShore Biopharma in the Dow Jones?

No, LakeShore Biopharma is not included in the Dow Jones index

When was LakeShore Biopharma the previous earnings report?

No data

When does LakeShore Biopharma earnings report?

The next expected earnings date for LakeShore Biopharma is 25 September 2024